Best Life Insurance for People With Heart Disease

Research Snapshot

• Topic: Life insurance for people with a history of heart disease (Health Conditions & High-Risk Life Insurance).
• Target buyer: A U.S. consumer with a history of heart disease who understands that eligibility and pricing may depend on the specific diagnosis, severity, cardiac testing, treatment, medications, symptoms, other risk factors, and overall stability.
• Platforms included (7): OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, Google.
• Research date: 2026-09-22 (authoritative run date). Platform-reported dates are provenance metadata only; DeepSeek reported 2026-06-01, and other platforms reported dates ranging from 2026-01-15 to 2026-09-22.
• Unique entities named: 21.
• Qualifying entities: 10.
• Eligibility rule: Named by at least two platforms during ranking discovery.
• Geography: United States. Several carriers are not licensed in New York, and product availability varies by state.

The Consensus Ranking

Questions This Section Answers

• What are the best life insurance carriers for people with heart disease in 2026, ranked by cross-platform AI consensus?
• Which heart-disease life insurance carriers were named by the most AI platforms, and how often did each appear?

The table below is the study's ranking authority. Platform mentions count only ranking-discovery mentions; they do not represent the number of platforms that later completed a fit assessment.

Which Option Is Best for Which Version of the Buyer Need?

Questions This Section Answers

• Which life insurance carrier should a buyer with heart disease choose if they want the lowest-cost fully underwritten term policy?
• Which carrier is best for a buyer with heart disease who has been declined elsewhere and needs guaranteed acceptance?
• Is Prudential or Lincoln Financial better for a heart-disease applicant who expects a table rating?

Buyer needs differ sharply in this market, and the ranking reflects general consensus rather than a single best answer for every cardiac profile.

1. Prudential

Questions This Section Answers

• Is Prudential worth it for life insurance with heart disease, and what are its main drawbacks?
• What should a buyer with heart disease verify before applying to Prudential for life insurance?

Prudential ranks first because it was the only carrier named by all seven platforms, at an average listed position of 1.29 and a best position of 1. Platform fit ratings ranged from "good" (OpenAI, DeepSeek, Google) to "strong" (Anthropic, Grok, Kimi) to "mixed" (Perplexity), which is itself a signal: the consensus is about relevance and underwriting reputation, not a verified price advantage.

Why it ranked here. Prudential received the most first-place votes of any carrier, including first-place rankings from Anthropic, DeepSeek, Grok, Kimi, and Perplexity ^[1]. Platforms consistently described individualized cardiac underwriting rather than rigid formulas, with credits for favorable clinical outcomes such as normal ejection fraction, completed cardiac rehab, and favorable lipid trends ^[4]. Google-reported evidence describes a formal underwriting credit program triggered by a normal maximal treadmill ECG, negative stress echocardiogram, normal nuclear scanning, or normal NT-proBNP within the prior year ^[6].

Best suited for. Applicants with stable, well-documented cardiac histories who want medically underwritten term coverage; applicants seeking larger face amounts or permanent coverage who can supply medical records, testing, and physician information; and consumers using an independent broker to compare Prudential's rating against multiple insurers.

Main strengths for this use case. Platforms describe willingness to review early-onset heart attacks (ages 35–39) that competitors auto-decline ^[7], expertise with combined cardiac and non-cardiac impairments such as heart disease plus diabetes ^[8], a rating-reconsideration privilege generally available about two years after issue if cardiac health improves ^[9], and term conversion to permanent coverage without new medical underwriting ^[10]. Google-reported evidence cites a documented case where a 51-year-old post-bypass applicant was offered Table 4 by Prudential and Nationwide ^[11]. .

2. Lincoln Financial

Questions This Section Answers

• Is Lincoln Financial or Prudential better for a heart-disease applicant who expects a table rating?
• Is Lincoln Financial worth it for life insurance with heart disease if the buyer wants term coverage with conversion?

Lincoln Financial ranks second, also named by all seven platforms, at an average listed position of 2.57 and a best position of 2. Fit ratings ranged from "strong" (Grok) to "good" (Anthropic, DeepSeek, Google) to "mixed" (OpenAI, Perplexity) to "uncertain" (Kimi).

Why it ranked here. Lincoln placed second or third on six of seven platforms. The distinguishing evidence is Google's report of up to four tables of favorable profile credits for cardiac histories and a Table Reduction Program that can upgrade eligible applicants up to age 70 with ratings up to Table 3 to Standard rates for coverage up to $10 million ^[12]. Anthropic reported that Lincoln's guidelines are particularly favorable for applicants 2+ years post-heart attack and that Lincoln does not require EKGs on LifeElements Level Term, IUL, and VUL products ^[13].

Best suited for. Applicants with stable, well-documented cardiac history who can qualify through full underwriting; applicants seeking conventional term coverage with a possible conversion option; and applicants needing permanent coverage who will evaluate indexed universal life costs, guarantees, and lapse risk.

Main strengths for this use case. A full-underwriting path exists when automated TermAccel underwriting is unsuitable or declines the applicant, and Lincoln states that a TermAccel decline may still be eligible for a fully underwritten LifeElements, UL, IUL, or VUL option with additional medical information ^[15]. Term products offer level-premium periods and conversion to qualifying permanent policies before the end of the level-premium period or attained age 70 ^[16]. Grok reported favorable stent guidelines (elective: 6-month wait, Table 1–2; post-MI: 12 months, Table 2–3) and consideration as early as 3 months post-minor single-vessel MI with ejection fraction above 50% ^[17].

Main limitations. Lincoln's published TermAccel preferred criteria state that preferred classes require no personal history of cardiovascular disease, and the WealthAccelerate IUL underwriting guide lists coronary artery disease, cardiomyopathy, congestive heart failure, and implantable defibrillators as disqualifying for that product ^[18].

3. Mutual of Omaha

Questions This Section Answers

• Which life insurance carrier for people with heart disease offers guaranteed acceptance with no health questions, and what does it cost?
• Is Mutual of Omaha worth it for a buyer with severe heart disease who needs final-expense coverage?

Mutual of Omaha ranks third with six platform mentions (85.7% share), an average listed position of 5.50, and a best position of 4. It is the highest-ranked carrier whose primary role in this market is guaranteed-issue and simplified-issue final-expense coverage rather than fully underwritten protection.

Why it ranked here. Mutual of Omaha is the consensus fallback. Platforms consistently described its guaranteed whole life product as available to ages 45–85 (50–75 in New York) with no medical underwriting, no health questions, and no medical exam, covering roughly $2,000–$25,000 ^[20]. Google reported a relatively liberal two-year lookback on the Living Promise Level Benefit, allowing applicants who had stents, open-heart surgery, heart attacks, or strokes more than two years ago to qualify for immediate level-benefit coverage ^[23].

Best suited for. Applicants ages 45–85, or ages 50–75 in New York, seeking approximately $2,000–$25,000 of permanent final-expense coverage; applicants with moderate-to-severe or poorly documented heart disease who want an option without medical underwriting; and buyers who prioritize guaranteed acceptance and fixed premiums over a larger death benefit or lowest cost per dollar of coverage.

Main strengths for this use case. Guaranteed-issue availability is the core value: no medical exam, no health questions, no MIB or MVR check for the guaranteed product ^[24]. Premiums are fixed after issue and based principally on age, sex, and selected death benefit rather than health ^[25]. Anthropic reported an A+ (Superior) A.M. Best rating and a policyholder-owned mutual structure ^[26]. Google rated pricing confidence "high" for this product line ^[27].

Main limitations. The two-year graded benefit is the most material tradeoff: for nonaccidental death during the first two years, the beneficiary generally receives 110% of premiums paid, while accidental death during that period receives the selected face amount ^[25].

4. John Hancock

Questions This Section Answers

• Is John Hancock worth it for life insurance with heart disease if the buyer has well-managed atrial fibrillation?
• Does John Hancock's Vitality program reduce premiums for a table-rated heart-disease applicant?

John Hancock ranks fourth with five platform mentions (71.4% share), an average listed position of 3.20, and a best position of 3. Its average position is better than Mutual of Omaha's, but it was named by fewer platforms.

Why it ranked here. John Hancock's distinguishing evidence is cardiac-specific underwriting nuance. Anthropic and Kimi both reported that John Hancock uses CHA2DS2-VASc stroke-risk scoring for atrial fibrillation and may offer Standard rates for scores of 0–1, where other carriers default to table ratings ^[29]. Anthropic also reported that John Hancock is more lenient than many competitors on family history of heart disease and may offer preferred rates where competitors downgrade ^[32].

Best suited for. Applicants with well-managed atrial fibrillation, especially low stroke risk per CHA2DS2-VASc scoring; individuals with family history of early heart disease who seek preferred rates; stable cardiac patients 12+ months post-stent or post-bypass with documented compliance and normal ejection fraction; and ages 35–60 seeking term coverage under $2 million with Vitality wellness credits.

Main strengths for this use case. Term coverage ranges from $250,000 to $30 million and universal life from $50,000 to $65 million, with term convertible to permanent without additional medical underwriting ^[33]. Vitality PLUS offers up to 25% off premium for healthy behaviors and can be added for as little as $2 per month on single-life permanent products ^[36]. Google reported April 2026 cardiac support tools for Vitality members, including discounted in-home AEDs and Garmin Index BPM blood pressure monitors ^[38]. Anthropic cited an A+ (Superior) A.M. Best rating ^[39].

Main limitations. John Hancock's published Simple Term with Vitality underwriting guide states that coronary disorder or vascular disease, including a history of stroke, heart attack, stent placement, or cardiomyopathy, is not eligible for that product ^[40].

5. Banner Life

Questions This Section Answers

• Which life insurance carrier for people with heart disease has the lowest cost after a table rating is applied?
• Is Banner Life worth it for a heart-disease applicant who wants term coverage with a conversion option?

Banner Life ranks fifth with five platform mentions (71.4% share), an average listed position of 4.60, and a best position of 4. Six of seven platforms rated the fit "good"; OpenAI and Perplexity rated it "mixed."

Why it ranked here. Banner's ranking rests on a structural pricing feature rather than a cardiac underwriting specialty. Anthropic reported that Banner bases table ratings off its Standard Plus rate class rather than Standard, which lowers the absolute cost of a given table rating ^[41]. Kimi quantified this: for a 50-year-old male at Table 4 on $500,000 of 20-year term, Banner's base rate of $82 per month becomes $164, versus $196–$210 at competitors, a savings of $32–$46 per month or $7,680–$11,040 over the policy life ^[44].

Best suited for. Applicants seeking competitively priced term coverage who will undergo medical-record review or an exam; applicants with stable, well-managed cardiac histories who can provide complete cardiology records, testing, treatment, medication, and symptom information; and applicants who may value conversion from term to Banner Life guaranteed universal life.

Main strengths for this use case. OPTerm offers 10-, 15-, 20-, 25-, 30-, 35-, and 40-year terms with coverage from $100,000 to $10 million or more, available to ages 20–75 for non-tobacco classes, renewable and convertible to Life Step UL before age 70 without additional underwriting ^[45]. An accelerated death benefit rider for terminal illness is included at no cost on all OPTerm and Life Step UL policies ^[48]. Banner holds an A+ (Superior) A.M. Best rating with a low NAIC complaint index of 0.16 ^[50]. Google reported that Banner disregards family history of coronary artery disease for tobacco-free applicants over age 70 ^[52]. .

6. Protective Life

Questions This Section Answers

• Is Protective Life worth it for life insurance with heart disease if the buyer is post-stent with stable coronary artery disease?
• What are Protective Life's main drawbacks for a heart-disease applicant who wants no-exam coverage?

Protective Life ranks sixth with five platform mentions (71.4% share), an average listed position of 6.20, and a best position of 5. Fit ratings split three "good" (Anthropic, Google, Kimi) against four "mixed" (DeepSeek, Grok, OpenAI, Perplexity).

Why it ranked here. Protective's evidence centers on moderate coronary artery disease and post-stent cases. Kimi reported that Protective is specifically identified as "strong on moderate CAD cases" among carriers serving cardiac patients, with fast APS review to expedite underwriting ^[53]. Google reported that Protective can offer coverage starting 12 months post-heart attack at Table 4–8 ratings and Table 2–4 for controlled atrial fibrillation on anticoagulants ^[54].

Best suited for. Applicants seeking conventional term coverage with 10- to 40-year options and at least $100,000 of coverage; applicants whose cardiac history is stable enough to qualify for accelerated underwriting or whose records support traditional underwriting; and applicants who value conversion to permanent insurance without a new medical exam.

Main strengths for this use case. Classic Choice Term offers 10-, 15-, 20-, 25-, 30-, 35-, and 40-year terms with coverage from $100,000 to $50 million and conversion options ^[55]. The Conversion Choice rider with ExtendCare permits conversion to permanent products without evidence of insurability or medical exams during the conversion window ^[56]. An accelerated death benefit rider is included at no extra cost ^[58]. Protective holds an A+ A.M. Best rating ^[59]. Google reported updated underwriting rules that prevent a family history of early heart disease from automatically blocking access to Best Class pricing ^[60].

Main limitations. Protective's PLUS accelerated underwriting eligibility checklist excludes anyone with a personal history of heart disease, heart attack, stroke, or heart or circulatory system surgery ^[61]. Google reported that any heart condition requiring a cardiac defibrillator is generally considered uninsurable ^[60].

7. Corebridge Financial

Questions This Section Answers

• Is Corebridge Financial worth it for life insurance with heart disease, and has its cardiac underwriting changed recently?
• Which Corebridge product should a heart-disease applicant choose between Select-a-Term and Guaranteed Issue Whole Life?

Corebridge Financial ranks seventh with four platform mentions (57.1% share), an average listed position of 3.00, and a best position of 1. Its average position is the third-best in the study, but it was named by only four platforms, which is why it ranks seventh under the study's ordering rule.

Why it ranked here. Corebridge received first-place rankings from Google and OpenAI ^[63]. Google rated the fit "strong," describing underwriters experienced with complex cardiac histories who work files manually rather than auto-declining, and competitive Special Class rates on rated Select-a-Term cases ^[65]. Anthropic cited Policygenius analysis naming Corebridge best for people with heart conditions, with best rates for pericarditis, aortic stenosis, and mitral stenosis ^[66].

Best suited for. Applicants with stable, well-documented heart disease who want traditional term or permanent coverage and will undergo medical underwriting; applicants seeking flexible term durations through Select-a-Term; and applicants who may not qualify for fully underwritten coverage and need to investigate simplified-issue or guaranteed-issue final-expense coverage.

Main strengths for this use case. Select-a-Term offers 18 customizable term lengths from 10 to 35 years with a minimum of $100,000 and conversion to permanent coverage without a new medical exam ^[67]. Guaranteed Issue Whole Life accepts applicants ages 50–80 with no health questions and no medical exam, covering $5,000–$25,000 ^[69]. Agile Underwriting+ provides no-exam approvals for qualifying applicants, with over 60% of term applications qualifying ^[71]. Corebridge holds an A (Excellent) A.M. Best rating ^[72]. Google reported Quality of Life accelerated benefit riders that pay out on a qualifying major heart attack ^[73].

Main limitations. Recent intelligence cited by Anthropic and Grok indicates Corebridge's historical heart-disease underwriting edge has softened in 2024–2025, with impaired-risk offers now described as "hit or miss" ^[74].

8. Transamerica

Questions This Section Answers

• Is Transamerica worth it for life insurance with heart disease if the applicant has multiple cardiac events or a prior decline?
• What are Transamerica's main drawbacks for a heart-disease applicant who wants living benefits?

Transamerica ranks eighth with four platform mentions (57.1% share), an average listed position of 5.75, and a best position of 4. Fit ratings split two "good" (Anthropic, Kimi) against five "mixed" (DeepSeek, Google, Grok, OpenAI, Perplexity).

Why it ranked here. Transamerica's evidence centers on complex and multi-event cardiac histories. Anthropic reported that Transamerica accepts cases with multiple cardiac events and offers table ratings such as Table 5 when most carriers decline, including a history of heart attack, stents, and atrial fibrillation stable on medication for years ^[77]. Kimi reported that Transamerica evaluates cases independently even after a prior decline by another carrier ^[79].

Best suited for. Applicants with stable, well-documented heart disease seeking medically underwritten term coverage; applicants who can provide recent cardiology records, testing, treatment history, and medication information; and applicants who value term conversion or qualifying accelerated death-benefit features.

Main strengths for this use case. Trendsetter Super provides level death-benefit term coverage for 10, 15, 20, 25, or 30 years and is renewable to age 105 ^[80]. Trendsetter LB adds qualifying chronic, critical, and terminal illness accelerated-benefit features, with heart attack among the described critical-illness examples ^[80]. Anthropic reported that heart disease with stents can qualify for day-one coverage through Transamerica when competitors would decline or grade ^[82]. Conversion to an available permanent policy generally does not require new underwriting when the converted amount is the same or lower ^[80].

Main limitations. Google reported that applicants with coronary artery disease or a history of heart attack are explicitly excluded from Transamerica's expanded nonmedical underwriting limits and must complete full traditional underwriting with MIB check, prescription history, paramedical exam, labs, and APS ^[83]. Google also reported that coronary artery disease and heart attacks make an applicant ineligible for Living Benefit riders on Trendsetter LB and the Financial Foundation IUL ^[85].

9. Pacific Life

Questions This Section Answers

• Is Pacific Life worth it for life insurance with heart disease if the applicant had a heart attack six months ago?
• Which Pacific Life product should a heart-disease applicant consider between Pacific Elite Term and Pacific Discovery Xelerator IUL?

Pacific Life ranks ninth with three platform mentions (42.9% share), an average listed position of 6.67, and a best position of 2. It received a second-place ranking from DeepSeek but eighth and tenth from Kimi and Perplexity, producing the widest rank spread in the study.

Why it ranked here. Pacific Life's evidence is unusually specific because its published impairment guide directly addresses cardiac conditions. OpenAI reported that the guide lists heart disease involving angina, angioplasty, bypass/CABG, heart attack, arrhythmia, valve conditions, and hypertension, with individual consideration or severity-dependent outcomes ^[86]. Anthropic and Google reported automatic declines for uninvestigated unstable angina, angioplasty within one month, CABG within three months, myocardial infarction within six months, and valve surgery within six months ^[87].

Best suited for. Applicants whose cardiac condition is stable, treated, investigated, and sufficiently remote from any recent heart attack, angioplasty, bypass, or valve surgery; applicants seeking traditionally underwritten term coverage, particularly Pacific Elite Term; and applicants who want possible conversion from term to an eligible Pacific Life permanent policy without new underwriting during the stated conversion period.

Main strengths for this use case. Pacific Elite Term offers 10-, 20-, and 30-year level-premium periods with full underwriting for all listed risk classes and conversion to eligible Pacific Life cash-value insurance without additional underwriting for up to ten years after issue or attained age 70 ^[89]. Google reported that Pacific Life does not require a treadmill stress test for applicants with known coronary artery disease, requiring instead a resting EKG and full cardiac records ^[90]. Anthropic reported that controlled atrial fibrillation receives Table 2–4 ratings depending on rate control and anticoagulation, and that standard rates may be possible at 5+ years post-MI with normal ejection fraction ^[91]. A Critical Illness Rider covering heart attack is included on Pacific Elite Term ^[92]. .

10. North American Company for Life and Health Insurance

Read the full North American Company for Life and Health Insurance fit review for supporting evidence and buying considerations.

North American ranks tenth with two platform mentions (28.6% share), an average listed position of 9.00, and a best position of 9. It is the only entity in the study named by exactly two platforms, which is the minimum eligibility threshold.

Why it ranked here. North American qualified because Anthropic and Kimi both named it, ranking it ninth. Anthropic rated the fit "good," citing liberal underwriting for controlled chronic conditions and living benefits that cover heart attack ^[93]. Kimi rated it "mixed," noting that it may serve well-documented, stable cardiac patients 5+ years post-event but is not a leader in cardiac underwriting ^[96].

Best suited for. Applicants seeking guaranteed permanent death-benefit coverage and willing to meet ongoing premium requirements; applicants whose cardiac condition is stable enough for traditional underwriting and who may qualify for a standard or rated policy; and buyers considering an IUL for death-benefit protection plus possible cash-value accumulation who understand policy-cost and lapse risks.

Main strengths for this use case. Custom Guarantee GUL provides a lifetime guaranteed death benefit with selectable guarantee duration and short-pay premium designs, plus accelerated-death-benefit endorsements for qualifying critical, chronic, and terminal illness at no additional premium in the cited material ^[97]. Builder Plus IUL 4 is designed for death-benefit protection and potential long-term cash-value accumulation with a no-lapse guarantee subject to specified premium payments ^[98]. Anthropic cited universal life rates 13–22% below the national average and A+ ratings from A.M. Best, S&P, and Fitch ^[99]. Google reported a Guaranteed Exchange Privilege allowing policyowners to switch from GUL to IUL at the same risk class without new evidence of insurability ^[101]. .

What the Cross-Platform Study Reveals About This Market

Questions This Section Answers

• What does the cross-platform AI consensus reveal about how life insurers underwrite heart disease?
• Why do AI platforms recommend different life insurance carriers for the same heart-disease applicant?

Three structural patterns emerge from the ten qualifying entities.

First, the market splits into two distinct product tiers that platforms treat almost as separate categories. Fully underwritten carriers — Prudential, Lincoln Financial, John Hancock, Banner Life, Protective Life, Transamerica, Pacific Life, and North American — compete on cardiac underwriting nuance, table ratings, and conversion features. Guaranteed-issue and simplified-issue carriers — Mutual of Omaha and Corebridge Financial's guaranteed-issue line — compete on acceptance certainty, coverage limits, and graded-benefit terms. No carrier in this study was described by platforms as strong in both tiers simultaneously.

Second, accelerated underwriting is consistently unavailable to applicants with significant cardiac histories. Banner Life excludes heart attack/heart disease and heart or blood-vessel surgery/disease ^[102]. Lincoln Financial's TermAccel preferred criteria exclude personal cardiovascular disease ^[103]. Protective Life's PLUS checklist excludes heart disease, heart attack, stroke, and heart or circulatory system surgery ^[104].

Where the AI Platforms Agreed

Questions This Section Answers

• Which life insurance carriers for heart disease do all major AI platforms agree on?

Platforms agreed on several points across entity boundaries.

• Prudential and Lincoln Financial belong on every shortlist. Both were named by all seven platforms, the only two carriers to achieve that ^[105].
• Guaranteed-issue coverage is a distinct fallback, not a substitute. Platforms consistently described Mutual of Omaha's guaranteed whole life as appropriate when medical underwriting is not realistic, with a two-year graded benefit and coverage capped around $25,000 ^[107].
• Cardiac history generally requires full underwriting. Across Banner Life, Lincoln Financial, Protective Life, John Hancock, Transamerica, and Pacific Life, platforms agreed that a disclosed cardiac history routes the application away from accelerated or no-exam processing ^[110]. .

Where the AI Platforms Disagreed

Questions This Section Answers

• Why do AI platforms disagree about which life insurance carrier is best for heart disease?

Disagreements were material and are preserved here rather than smoothed into false consensus.

• Prudential's cardiac advantage. Anthropic, Grok, and Kimi described Prudential as the industry leader for cardiac cases with individualized underwriting ^[116]. OpenAI concluded that public materials do not establish a current diagnosis-specific cardiac advantage ^[119]. Perplexity rated the fit "mixed" and cited hard exclusions for congestive heart failure treatment and recent arrhythmia, pacemaker, or defibrillator events ^[120].
• Corebridge's current underwriting direction. Google and Policygenius-derived evidence retained a positive assessment of Corebridge for heart conditions ^[121]. Anthropic and Grok reported a documented softening in 2024–2025, with impaired-risk offers now "hit or miss" ^[123].
• Transamerica's simplified-issue availability. Kimi cited a simplified-issue term product up to $400,000 ^[125]. DeepSeek could not verify a currently active simplified-issue term product or its face-amount limit ^[126].

How Buyers Should Choose

Questions This Section Answers

• What should a buyer check before choosing a life insurance carrier for heart disease?
• How should a heart-disease applicant compare life insurance quotes across carriers?

The study supports a staged approach rather than a single-carrier decision.

Step 1: Determine whether full underwriting is realistic. If the cardiac condition is stable, treated, investigated, and sufficiently remote from any recent event, the fully underwritten tier — Prudential, Lincoln Financial, Banner Life, Protective Life, Pacific Life, Transamerica, John Hancock, and North American — is where the largest death benefits and lowest cost per dollar of coverage are found. If the condition is recent, severe, unstable, or poorly documented, the guaranteed-issue tier — Mutual of Omaha and Corebridge Financial's guaranteed-issue line — is the realistic path.

Step 2: Match the carrier to the specific cardiac profile. Atrial fibrillation with low stroke risk points toward John Hancock ^[127]. Moderate coronary artery disease or post-stent status points toward Protective Life ^[129]. Multiple cardiac events or a prior decline points toward Transamerica ^[130].

Methodology

This index was produced from one standardized prompt sent once to each of seven AI platforms: OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, and Google. The prompt asked which life insurance carriers are generally worth considering for applicants with heart disease and why, specifying that eligibility and pricing may depend on the specific diagnosis, severity, cardiac testing, treatment, medications, symptoms, other risk factors, and overall stability.

The ranking order is based on platform mentions first, then average listed position, then best listed position. Ten entities qualified by being named by at least two platforms. The final ranking table is the sole authority for rank, platform mentions, platform share, average listed position, and best position.

Platform mentions count only ranking-discovery mentions. They do not represent the number of platforms that later completed a fit assessment. For example, Mutual of Omaha was named by six platforms but assessed by six; John Hancock was named by five platforms and assessed by five; Corebridge Financial was named by four platforms and assessed by four.

Citations are platform-reported evidence, not independently verified facts. Company-owned sources are distinguished from independent sources in the consolidated source list.

Methodology Limitations

Several limitations apply to this study and should be weighed before acting on it.

• One prompt, one run. The study used a single standardized prompt sent once to each platform. AI answers can vary by date, wording, location, account state, model, interface, browsing configuration, and the sources retrieved.
• Platform-reported dates differ from the run date. The authoritative research date is 2026-09-22. DeepSeek reported 2026-06-01, and other platforms reported dates ranging from 2026-01-15 to 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.
• Platform mentions are not fit assessments. A carrier named by seven platforms during ranking discovery was not necessarily assessed by all seven, and a carrier named by two platforms may have been assessed by more.
• No cardiac-specific pricing was verified. Every platform that addressed pricing reported low or unclear pricing confidence for cardiac applicants. No carrier published a cardiac-specific rate table in the retrieved evidence.
• Product names conflict across platforms. Prudential's current product lineup, Pacific Life's Xelerator IUL, Transamerica's simplified-issue term product, and North American's Standard Plus class all produced conflicting platform descriptions that were not resolved. .

Final Verdict

Prudential is the consensus leader for life insurance applicants with heart disease, named by all seven platforms studied at an average listed position of 1.29. Lincoln Financial is the strongest fully underwritten alternative, also named by all seven platforms, with table-credit and table-reduction programs that platforms described as distinctive. Mutual of Omaha is the leading guaranteed-issue fallback for applicants who cannot qualify medically, with the tradeoff of a two-year graded benefit and coverage capped around $25,000.

The most important finding for buyers is that no carrier in this study publishes cardiac-specific pricing, and every carrier that offers accelerated underwriting excludes significant cardiac histories from it. The practical path is an independent broker, informal pre-underwriting with multiple carriers, and a written comparison of the offered table rating, required testing, waiting period, and premium before any formal application.